PriceSpective seeks to expand our thought leadership and value by publishing industry-specific reports on topics that are evolving and of high interest within the health industry. By pooling our expertise in pricing, market access and payer understanding, we gain insight into managed care philosophy thus allowing us to deliver actionable insights to our customers and enlightening their investment decisions. Drawing on our network of over 1,000 payers and thought leaders, we conduct primary research with an expert panel allowing us to identify trends and track how perceptions build and change over time. Coupled with up to date market metrics, our customers will gain a unique and comprehensive overview of these high value topics. Below are links for information on our first two reports of the Managed Markets Integrated Intelligence (M2I2) series. Pricespective Biosimilar Perceptions and Expectations in the US |
PriceSpective is a leading global value strategy consultancy, specializing in innovative strategies to define, drive and capture value for biopharmaceutical and medical technology assets. Through our unique integrated approach to value strategy we are well positioned to help our customers optimize payer strategies for pricing, reimbursement, evidence and implementation.
